Cytomegalovirus Antigen And Igg Ab Panel
DiscoveryProbe? Endocrinology and Hormones-related Compounds Panel |
|||
L1008-5 | ApexBio | 5 mg/well | 2829.6 EUR |
Description: A wide range of well-characterized bioactive molecules that covers various targets related to endocrinology and hormones, including androgen receptor, estrogen/progestogen receptor and RAAS etc. Facilitate your research towards the insights of diabetes, thyroid disorders and cancer etc. |
Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antigen and igg ab panel reagents distributed by Genprice. The Cytomegalovirus Antigen And Igg Ab Panel reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antigen Group: And Igg
Human Antigen Processing and Presentation Primer Library |
||
Real Time Primers | 1 set | 657.6 EUR |
Recombinant Foot-and-mouth disease 3ABC Antigen |
||
EnoGene | 100ug | 395 EUR |
JBS True Blue |
||
MiTeGen | 300 µl | 16 EUR |
Description: JBS True Blue |
||
Leukocyte Antigen A, B and C (HLA-ABC) Antibody |
||
Abbexa | 0.2 mg | 678 EUR |
Leukocyte Antigen A, B and C (HLA-ABC) Antibody |
||
Abbexa | 0.5 mg | 994.8 EUR |
Leukocyte Antigen A, B and C (HLA-ABC) Antibody |
||
Abbexa | 0.2 mg | 678 EUR |
Rat Anti centriole and centrosome antibody IgG ELISA kit |
||
BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Rat Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Cytomegalovirus Early Nuclear Antigen (CMV-EA Nuclear) Antibody (FITC) |
|||
abx411281-01mg | Abbexa | 0.1 mg | 610.8 EUR |
Human Cytomegalovirus IgG Antibody (Anti-CMV IgG) ELISA Kit |
|||
abx354612-96tests | Abbexa | 96 tests | 548.4 EUR |
Cytomegalovirus gB Late Cytoplasmic Antigen (CMV-LA gB Cytoplasmic) Antibody |
|||
abx411282-02mg | Abbexa | 0.2 mg | 678 EUR |
Cytomegalovirus Antibody / CMV / PP65 |
|||
V2332-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
V2332-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
V2332SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
V2333-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
V2333-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
V2333SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Human Cytomegalovirus (CMV) IgG ELISA Kit (Direct EIA) |
|||
EK7032 | BosterBio | 96wells/kit, with removable strips. | 573.6 EUR |
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody |
|||
abx411283-02mg | Abbexa | 0.2 mg | 678 EUR |
Cytomegalovirus pp65 Antibody |
|||
abx021650-1mg | Abbexa | 1 mg | 1387.2 EUR |
Anti-Human Cytomegalovirus antibody |
|||
STJ16100451 | St John's Laboratory | 1 mL | 1092 EUR |
Cytomegalovirus gB Protein |
|||
20-abx260105 | Abbexa |
|
|
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC) |
|||
abx411284-01mg | Abbexa | 0.1 mg | 610.8 EUR |
Cytomegalovirus gH (CMV gH) Antibody |
|||
abx415688-01mg | Abbexa | 0.1 mg | 777.6 EUR |
Mouse antibody for Cytomegalovirus |
|||
887 | Virostat | 100 ug | 431.93 EUR |
Description: This is Mouse monoclonal FITC conjugated antibody against Cytomegalovirus pp65 for WB, ELISA. |